Disposition kinetics of caffeine and paraxanthine in Nile tilapia (Oreochromis niloticus): Characterization of the main metabolites

Archives of Environmental Contamination and Toxicology

Volumn 60, Issue 4, 2011, Pages 654-664

  Gómez Martínez, Lisbeth E ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLURIC ACID; 1 METHYLXANTHINE; CAFFEINE; PARAXANTHINE;

ALKALOID; BIOACCUMULATION; BIOLOGICAL DEVELOPMENT; BLOOD; CICHLID; CONCENTRATION (COMPOSITION); DOSE-RESPONSE RELATIONSHIP; ECOTOXICOLOGY; HALF LIFE; METABOLITE; REACTION KINETICS; REPRODUCTIVE BIOLOGY; RISK ASSESSMENT; TOXICITY TEST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WATER; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FIRST PASS EFFECT; GILL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; MALE; NONHUMAN; OREOCHROMIS NILOTICUS; PRIORITY JOURNAL; TOXICOKINETICS;

ANIMALS; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CICHLIDS; MALE; THEOPHYLLINE; TISSUE DISTRIBUTION; WATER POLLUTANTS, CHEMICAL;

MAMMALIA; OREOCHROMIS NILOTICUS; TILAPIA;

EID: 79955933736     PISSN: 00904341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00244-010-9571-9     Document Type: Article

References (48)

1. Arnaud MJ (1985) Comparative metabolic disposition of [1-Me 14C] caffeine in rats, mice and Chinese hamsters. Drug Metab Dispos 13:471-478
2. Barnes KK, Kolpin DW, Furlong ET, Zaugg SD, Meyer MT, Barber LB (2008) A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States. Groundwater. Sci Total Environ 402:192-200
3. Beach CA, Mays DC, Sterman BM, Gerber N (1985) Metabolism, distribution, seminal excretion and pharmacokinetic of caffeine in the rabbit. J Pharmacol Exp Ther 233:18-23 (Pubitemid 15083521)
4. Bech BH, Nohr EA, Vaeth M, Henriksen TB, Olsen J (2005) Coffee and fetal death: a cohort study with prospective data. Am J Epidemiol 162:983-990 (Pubitemid 41619469)
5. Berthou F, Guillois B, Riche C, Dreano E, Aigrain J, Beaune PH (1992) Interspecies variation in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22:671-680
6. Blanchard J, Sawers SJA, Jonkman JHJ, Tang-Liu DS (1985) Comparison of the urinary metabolite profile of caffeine in young and elderly males. Br J Clin Pharmacol 19:225-232 (Pubitemid 16216338)
7. Bonati M, Latini R, Tognoni, Young JF, Garattini S (1985) Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat and mouse. Drug Metab Rev 15:1355-1383 (Pubitemid 15028349)
8. Bortolotti A, Jiritano L, Bonati M (1985) Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine in the rat. Drug Metab Dispos 13:227-231 (Pubitemid 15114388)
9. Buerge IJ, Poiger T, Muller MD, Buser HR (2003) Caffeine, an anthropogenic marker for wastewater contamination of surface waters. Environ Sci Technol 37:691-700 (Pubitemid 36236683)
10. Buhler DR, Wang-Buhler JL (1998) Rainbow trout cytochrome P450s: Purification, molecular aspects, metabolic activity, induction and role in environment monitoring. Comp Biochem Physiol C Toxicol Pharmacol 121:107-137 (Pubitemid 28529358)
11. Burguess JW (1982) Chronic exposure to caffeine during early development modifies spatial behavior in juvenile jewel fish schools. Pharmacol Biochem Behav 17:137-140
12. Chen YH, Huang YH, Wen CC, Wang YH, Chen WL, Chen LC et al (2008) Movement disorder and neuromuscular change in zebrafish embryos after exposure to caffeine. Neurotoxicol Teratol 30:440-447
13. Dorrbecker SH, Ferraina RA, Dorrbecker BR, Kramer PA (1987) Caffeine and Paraxanthine pharmacokinetics in the rabbit: concentration and product inhibition effects. J Pharmacokinet Biopharm 15:117-132 (Pubitemid 17121513)
14. Eteng MU, Eyong EU, Akpanyung EO, Agiang MA, Aremu CY (1997) Recent advances in caffeine and theobromine toxicities: a review. Plant Foods Hum Nutr 51:231-243 (Pubitemid 28205485)
15. Gadagbui BK, Addy M, Goksoyr A (1996) Species characteristics of hepatic biotransformation enzymes in two tropical freshwater teleosts, tilapia (Oreochromis niloticus) and mudfish (Clarias anguillaris). Comp Biochem Physiol C Toxicol Pharmacol 114:201-211 (Pubitemid 26300479)
16. Gagné F, Blaise C, André C (2006) Ocurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhyncus mykiss) hepatocytes. Ecotoxicol Environ Saf 64:329-336
17. Grant DM, Tang BK, Kalow W (1983) Variability in caffeine metabolism. Clin Pharmacol Ther 33:591-602 (Pubitemid 13098529)
18. Grosso L, Bracken MB (2005) Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 15:460-466 (Pubitemid 40828352)
19. Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR, Bracken MB (2006) Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction. Am J Epidemiol 163:1035-1041 (Pubitemid 43987596)
20. Hattis D (1991) Use of biological markers and pharmacokinetics in human health risk assessment. Environ Health Perspect 229:229-238
21. James M (1987) Conjugation of organic pollutants in aquatic species. Environ Health Perspect 71:97-103
22. Jorritsma U, Schrader E, Klaunick G, Kapitulnick J, Hirsch-Ernst KI, Kahl GF et al (2000) Monitoring of cytochrome P-450 1A activity by determination of the urinary pattern of caffeine metabolites in Wistar and hyperbilirubinemic Gunn rats. Toxicology 144:229-236 (Pubitemid 30201641)
23. Kalow W, Tang BK (1993) The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 53:503-514 (Pubitemid 23161197)
24. Klebanoff MA, Levine RJ, DerSimonian R, Clemens JD, Wilkins DG (1999) Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion. N Engl J Med 341:1639-1644
25. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB et al (2002) Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36:1202-1211 (Pubitemid 34228893)
26. Kwon Y (2001) Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientist. Kluwer Academic, New York, NY, pp 179-180
27. Latini R, Bonati M, Marzi E, Garattini S (1981) Urinary excretion of an uracilic metabolite of caffeine from caffeine by rat, monkey and man. Toxicol Lett 7:267-272 (Pubitemid 11188257)
28. Lelo A, Birkett DJ, Robson RA, Miners JO (1986) Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophilline in man. Br J Clin Parmacol 22:177-182 (Pubitemid 17174115)
29. Lelo A, Kjellen G, Birkett DJ, Miners JO (1989) Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J Pharmacol Exp Ther 248:315-319 (Pubitemid 19063507)
30. Martin AP, Palumbi SR (1993) Body size, metabolic rate, generation time and the molecular clock. Proc Natl Acad Sci USA 90:4087-4091 (Pubitemid 23134171)
31. McGowan JD, Altman RE, Kanto WP (1988) Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 81:1092-1094
32. Metcalfe C (2009) Tracking the sources of coastal zone contamination in the Maya Riviera Region of Mexico. Caribbean coastal pollution project. www.inweh.unu.edu/Coastal/POPs/Passivesampler/PSReport-Dec2009.pdf
33. Ming-Hwang S, Lie-Chwen L, Chung-Hao C, Yu-Tse W, Yen-Hu H, Tung-Hu T (2006) Hebatobiliary excretion and brain distribution of caffeine in rats using microdialysis. Anal Chim Acta 566: 265-270
34. Momoi N, Tinney JP, Liu LJ, Elshershari H, Hoffmann PJ, Ralphe JC et al (2008) Modest maternal caffeine exposure affects developing embryonic cardiovascular function and growth. Am J Physiol Heart Circ Physiol 294:H2248-H2256
35. Moore MT, Greenway SL, Farris SL, Guerra B (2008) Assessing caffeine as an emerging environmental concern using conventional approaches. Environ Contam Toxicol 54:31-35
36. Nehlig A (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev 23:563-576
37. Numata M, Fawcet JP, Rosengren RI (2008) Induction of in vitro EROD activity and in vivo caffeine metabolism in two species of New Zealand birds. Environ Toxicol Pharmacol 25:358-364
38. Organisation for Economic Co-operation and Development SIDS (2001) Caffeine screening information data set. UNEP Publications
39. Rotchell JM, Steventon GB, Bird DJ (2000) Catalytic properties of CYP1A isoforms in the liver of an agnathan (Lampetra fluviatilis) and two species of teleost (Pleuronectes flesus, Anguilla anguilla). Comp Biochem Physiol C Toxicol Pharmacol 125:203-214 (Pubitemid 30249057)
40. Sarasquete C, Segner H (2000) Cytochrome P4501A (CYP1A) in teleostean fishes. A review of immunohistochemical studies. Sci Total Environ 247:313-332
41. Sawynok J (1995) Pharmacological rationale for the clinical use of caffeine. Drugs 49:37-50
42. Shumaker RC (1986) PkCalc: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev 17:331-348
43. Signorello LB, Nordmark A, Granath F, Blot WJ, McLaughlin JK, Anneren G et al (2001) Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstet Gynecol 98:059-1066
44. Tallarida RJ, Murray RB (1986) Manual of pharmacological calculations with computer programs, 2nd edn. Springer, New York, NY, pp 19-22
45. Tang-Liu DD, Williams RL, Riegelman S (1983) Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 224:180-185 (Pubitemid 13171047)
46. Viarengo A, Lowe D, Bolognesi C, Fabbri E, Koehler A (2007) The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms. Comp Biochem Physiol C Toxicol Pharmacol 146:281-300 (Pubitemid 47127013)
47. Walton K, Dorne JL, Renwick AG (2001) Uncertainty factors for chemical risk assessment: Interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Food Chem Toxicol 39:667-680 (Pubitemid 32523999)
48. World Health Organization (1991) International Agency for Research on Cancer (IARC) monograph, vol 51: coffee, tea, mate, methylxanthines and methylgloxal. World Health Organization, Lyon, France